NCT03687502View on ClinicalTrials.gov

The Role of Contrast Enhanced Ultrasound in Appendicitis

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

March 26, 2021

Study Completion Date

July 5, 2022

Conditions
Acute Appendicitis
Interventions
DRUG

Sulfur hexafluoride lipid-type A microspheres

Contrast Enhanced Ultrasound of the appendix

Trial Locations (1)

64108

Children's Mercy Kansas City, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT03687502 - The Role of Contrast Enhanced Ultrasound in Appendicitis | Biotech Hunter | Biotech Hunter